Cargando…
Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinoma
BACKGROUND: Metastatic sarcomatoid renal cell carcinoma (sRCC) is an aggressive variant of RCC with generally poor prognosis. Treatment with vascular endothelial growth factor inhibitors or chemotherapy generates only short-lived responses. Recent research has suggested a role for combination checkp...
Autores principales: | George, Gemlyn, Schmidt, Laura, Tolat, Parag, Riese, Mathew, Kilari, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057424/ https://www.ncbi.nlm.nih.gov/pubmed/32114501 http://dx.doi.org/10.1136/jitc-2020-000584 |
Ejemplares similares
-
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
por: Noguchi, Go, et al.
Publicado: (2018) -
Sarcomatoid Renal Cell Carcinoma Metastasis to the Penis
por: Liou, Victor D., et al.
Publicado: (2015) -
Sarcomatoid renal cell carcinoma with rhabdoid features
por: Al-Saidi, Nagla Ahmed, et al.
Publicado: (2013) -
Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
por: Lichtbroun, Benjamin J., et al.
Publicado: (2023) -
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
por: Rini, Brian I, et al.
Publicado: (2022)